A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy Volunteer

In brief

This is a multiple part, multiple cohort study evaluating single and multiple ascending doses, relative bioavailability, food effect, and drug-drug interaction of NX-5948 in healthy volunteers.

Key facts

Study ID

NCT06717269

Run by

Nurix Therapeutics, Inc.

People needed

223

Starts

2024-11-30

Expected to finish

2026-05-01

Last updated by the study team

2026-07-28

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

Where it is running

• Celerion — Phoenix, Arizona, United States
• Celerion — Lincoln, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.